Please ensure Javascript is enabled for purposes of website accessibility

skin care

May 18, 2026

Elanco Launches Befrena, Breakthrough Addition to the $1.3B US Canine Dermatology Market

Elanco Animal Health Incorporated (NYSE: ELAN) recently announced the phased launch of Befrena (tirnovetmab), a new anti-IL-31 monoclonal antibody (mAb) injection for treatment of canine allergic and atopic dermatitis. The […]

Feb 26, 2026

FDA Approves NUMELVI from Merck Animal Health for the Control of Pruritus in Dogs

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc.  in Rahway, New Jersey, has announced the U.S. […]